Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Summary

This reports provides a data-driven overview of the current and future competitive landscape in Aicardi-Goutieres Syndrome therapeutics.

Synopsis

  • There will be more than 4,000 prevalent cases of AGS each in 2022 across the 16 countries covered in GlobalData’s epidemiology forecast.
  • No FDA-approved marketed drugs are available for AGS, only symptomatic treatment is indicated for disease management.
  • The drug currently in late-stage clinical development targets tyrosine kinase.
  • Non-commercial sponsors dominate clinical trial development in AGS.
  • No deals involving companies developing AGS assets were seen over the past 10 years.
  • No regulator filing or commercial launch is expected for AGS in the next 18 months.
Scope

GlobalData’s Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include-
  • Disease Landscape
  • Disease Overview
  • Epidemiology Overview
  • Treatment Overview
  • Marketed Products Assessment
  • Pipeline Assessment
  • Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
  • Late-stage Pipeline Drugs
  • Phase Transition Success Rate and Likelihood of Approval
  • Clinical Trials Assessment
  • Breakdown of Trials by Phase, Status, Sponsors and Geography
  • Enrolment Analytics, Site Analytics, Feasibility Analysis
  • Deals Landscape
  • Commercial Assessment
  • Key Market Players
  • Future Market Catalysts
Reasons to Buy
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the Aicardi-Goutieres Syndrome market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Aicardi-Goutieres Syndrome market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.


  • Key Findings
  • Disease Overview
  • Epidemiology Overview
    • Epidemiology Overview: Total Prevalent Cases of AGS in 2022 and 2027
      • Table Epidemiology Overview: Total Prevalent Cases of AGS in 2022 and 2027
  • Treatment Overview
    • Treatment Guidelines
  • Marketed Drugs Assessment
    • Marketed Drugs - Leading Marketed Drugs in AGS
  • Pipeline Drugs Assessment
    • Pipeline Drugs Overview - Pipeline and Pre-clinical Drugs in AGS
    • Pipeline Drugs Overview - Inactive/Withdrawn/Discontinued Drugs in AGS
    • Pipeline Drugs - Overview by Development Stage
    • Pipeline Drugs - Overview by Molecule Type
    • Pipeline Drugs - Overview by Mechanism of Action
    • Pipeline Drugs - Overview by Route of Administration
    • Pipeline Drugs - Phase Transition Success Rates and Likelihood of Approval in Genetic Disorders
  • Clinical Trials Assessment
    • Clinical Trials in AGS - Historical Overview
    • Clinical Trials in AGS - Overview by Phase
    • Clinical Trials in AGS - Overview by Status
    • Clinical Trials in AGS - Geographic Overview
    • Clinical Trials in AGS - Top 20 Sponsors with Breakdown by Phase
    • Clinical Trials in AGS - Top 20 Sponsors with Breakdown by Status
    • Clinical Trials in AGS - Enrollment Data
    • Clinical Trials in AGS - Overview of Sites by Geography
    • Clinical Trials in AGS - Top 20 Countries for Trial Sites
    • Clinical Trials in AGS - Top 20 Sites Globally
    • Clinical Trials - Feasibility Analysis: Geography Overview
    • Clinical Trials - Feasibility Analysis: Benchmark Models for AGS
  • Deals Landscape
    • Deals Landscape - Mergers, Acquisitions, and Strategic Alliances in AGS
  • Commercial Assessment
    • Commercial Assessment - Key Market Players in AGS
  • Future Market Catalysts
    • Future Market Catalysts - Upcoming Market Catalysts in AGS
  • Appendix
    • Methodology
    • Methodology - PTSR and LoA Analysis
    • About the Authors
  • Contact Us
    • Contact Us - A Global Network of Offices

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings